OSIRIS THERAPEUTICS, INC.·4

Mar 16, 4:43 PM ET

Neumayer Matthew Paul 4

4 · OSIRIS THERAPEUTICS, INC. · Filed Mar 16, 2010

Insider Transaction Report

Form 4
Period: 2010-03-12
Neumayer Matthew Paul
Principal Accounting Officer
Transactions
  • Award

    Incentive Stock Option

    2010-03-12$7.74/sh+4,000$30,9608,000 total
    Exercise: $7.74From: 2011-03-12Exp: 2020-03-12Common Stock (4,000 underlying)
Footnotes (1)
  • [F1]Option vests in four equal installments commencing upon the first anniversary of the grant date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -